Results 181 to 190 of about 58,168 (261)

Epicardial adipose tissue‐linked leukotriene and cytokine signalling pathways – novel targets for prevention of obesity‐ and diabetes‐linked ventricular arrhythmia

The Journal of Physiology, EarlyView.
Kelly A. Aromolaran, Ademuyiwa S. Aromolaran   +1 more
wiley   +1 more source

Targeting the ERK2 Signaling Pathway With Frog Skin‐Derived Bioactive Peptides: Insights From Molecular Modeling, Molecular Dynamics, and Physicochemical Features

ChemistryOpen, Volume 15, Issue 9, September 2026.
Frog skin‐derived peptides are screened for prospective ERK2 inhibitors using docking calculations, molecular dynamics, MM/GBSA binding energy calculations, and physicochemical properties. The results propose that dermaseptin‐B3, dermaseptin‐PD‐1, and ascaphin‐8 can act as effective inhibitors of ERK2, warranting further in‐depth in vitro and in vivo ...
Nahlah Makki Almansour, Mahmoud M. H. Abdelhamid, Zahraa Alali, Mahmoud A. A. Ibrahim   +3 more
wiley   +1 more source

IL-37 drives temozolomide resistance in glioblastoma via MAPK pathway activation. [PDF]

Oncol Lett
Wang Y, Liu Y, Wang J, Rong W, Song X.
europepmc   +1 more source

Understanding the Molecular Processes of Obesity and the Anti‐Obesity Properties of Bioactive Substances Found in Tea

Phytochemicals in Food and Medicine, Volume 1, Issue 3, September 2026.
ABSTRACT Obesity, a severe worldwide health concern, is characterized as an excessive deposit of fat in the human body. It has various ramifications that endanger human health and increase the financial expense. Obesity raises the risk of several illnesses, notably cardiovascular disease, NALFD, and diabetes, and has been associated with shorter ...
Sakhawat Riaz, Fan Wenni, Danish Kamal, Umber Mubeen, Abul Hassan, Arslan Ahmed, Munir Ahmed   +6 more
wiley   +1 more source

Targeted degradation of MK2 is insufficient to block inflammatory cytokine production in human cells due to cooperativity with MK3 and MK5. [PDF]

Front Immunol
Yang B, Fang G, Marx I, Liu G, Skouras S, Sharma K, Walther DM, Bollinger Martinez S, Hubeau C, Shi Y, De Savi C, Huang X, Huhn A, Sawant R, Proctor WR, Dixit VS, Dong H, Weiss MM, Mainolfi N, Slavin A, Long AJ, Williams JA, Byrne FR.   +22 more
europepmc   +1 more source

Peripheral κ opioid receptor in pain and inflammation: From molecular signalling and gene expression to drug discovery

British Journal of Pharmacology, Volume 183, Issue 17, Page 5157-5189, September 2026.
The κ opioid receptor (κ receptor, KOR) is a G protein‐coupled receptor with well established roles in analgesia and immune modulation. Although historically studied primarily in the central nervous system (CNS), growing evidence indicates that κ signalling in peripheral tissues plays an important role in regulating pain, inflammation and immune ...
Rumsha Khan, Elena C. A. Becker, Boglarka B. Bata, Christian W. Gruber   +3 more
wiley   +1 more source

Research Progress on Anti-Inflammatory and Antioxidant Mechanism of Artemether Based on MAPK/NF-κB Signaling Pathway. [PDF]

Int J Mol Sci
Yang M, Feng K, Li Y, Zeng S, Ma H, Feng H.   +5 more
europepmc   +1 more source

Molecular Mediators Associated With Myelination, Demyelination, and Remyelination in the Peripheral Nervous System

Journal of the Peripheral Nervous System, Volume 31, Issue 3, September 2026.
ABSTRACT The peripheral nervous system (PNS) is responsible for innervating all regions of the body outside of the central nervous system (CNS), the latter consisting of the brain, spinal cord, and optic nerves. While myelin is an essential component for the efficient functioning of both CNS and peripheral nerve cells, it is particularly important for ...
Kathleen Margaret Hagen, Shalina Sheryl Ousman   +1 more
wiley   +1 more source

Phosphoproteome-Entailed Kinase-Substrate Landscape of Human-DENV-2 Interaction. [PDF]

Int J Mol Sci
Jabbar AA, Shaji V, Anil A, Nisar M, Soman S, Prasad G, Abhinand CS, Modi PK, Madanan MG, Jayanandan A, Pilankatta R, Raju R.   +11 more
europepmc   +1 more source

Anti‐inflammatory agents in atherosclerosis—and a need for reform: Extraordinary claims require extraordinary evidence

Journal of Internal Medicine, Volume 300, Issue 3, Page 258-283, September 2026.
Abstract Since 1858, human atherosclerotic plaques have been shown to contain immune cells. But are these cells suitable therapeutic targets? Dozens of clinical trials of anti‐inflammatory agents other than colchicine have been performed in patients with clinically evident atherosclerosis.
Kevin Jon Williams
wiley   +1 more source